Minerva Neurosciences, Inc.
NASDAQ:NERVBiotechnology
-$0.30 today
- Market cap
- $108.64M
- Beta
- -0.11
- P/E (TTM)
- -0.2
- EPS (TTM)
- -$8.46
Volume 0.28M
Average 0.21M
NERV Interest Income
Income earned on cash, deposits, and investments held by the company.
Minerva Neurosciences, Inc.NASDAQ: NERV
Interest Income · Q2 FY2026 · quarter ended Jun 2026
Interest income growth accelerates
Q2 FY2026 interest income of $569.59K rose 316.8% year over year, ahead of the +118.3% change in trailing-twelve-month interest income. Sequentially, it fell 9.5% from the prior quarter. Over 3 fiscal years it compounded at +19.4% a year.
Context
- Interest income increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +316.8% holds above the trailing-twelve-month pace of +118.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Interest Income history
USD · from the income statement
- Latest · FY2025
- 948.12K USD
- Year-over-year change
- -25.5%
- 4-year CAGR
- +175.3%
| Period | Period end | Interest Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 948.12K | -25.5% |
| FY2024 | 2024-12-31 | 1.27M | -11.5% |
| FY2023 | 2023-12-31 | 1.44M | +158.0% |
| FY2022 | 2022-12-31 | 556.95K | +3272.2% |
| FY2021 | 2021-12-31 | 16.52K | — |
Interest Income vs competitors
How NERV compares with its peers on the latest reported figures
- NERV's LTM Jun 2026 interest income of $1.85M is the 2nd highest of the 4 companies compared; the peer median is $1.75M.
- Its year-over-year change of +118.3% is the highest of 3, against a peer median of +22.3%.
- Over three fiscal years its annual growth of +19.4% compares with a peer median of +1.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Dec 2025 | $1.93M | +95.9% | -1.7% | — | |
| LTM Jun 2026 | $1.85M | +118.3% | +19.4% | — | |
| LTM Mar 2026 | $1.75M | -51.3% | +3.7% | 203.5% | |
NRXSNeurAxis, Inc. | LTM Mar 2026 | $0 | — | — | 0.0% |
| Peer median (excluding NERV) | $1.75M | +22.3% | +1.0% | 101.7% | |
Competitors are the stored peer set for NERV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Gross Margin | — | — | — | — | — |
| Research & Development | 32.04M | 14.65M | 12.71M | 11.9M | 5.76M |
| Selling, General & Admin | 13.33M | 10.58M | 10.41M | 9.95M | 9.34M |
| Operating Expenses | 45.37M | 25.23M | 23.12M | 21.85M | 15.1M |
| Depreciation & Amortization | 101.79K | 8.51K | 30.98K | 22.47K | 5.44K |
| EBITDA | (45.28M) | (24.69M) | (21.69M) | 6.02M | (293.42M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (45.37M) | (25.23M) | (23.12M) | (21.85M) | (15.1M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 16.52K | 556.95K | 1.44M | 1.27M | 948.12K |
| Interest Expense | 6.33M | 7.41M | 8.28M | 4.56M | 0 |
| Other Income / Expenses | (6.34M) | (6.88M) | (6.89M) | 23.29M | (278.32M) |
| Income Before Tax | (51.71M) | (32.11M) | (30.01M) | 1.44M | (293.42M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | (1.8M) | 0 | 0 | 0 | 0 |
| Net Income | (49.91M) | (32.11M) | (30.01M) | 1.44M | (293.42M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (9.35) | (6.01) | (4.61) | 0.19 | (34.67) |
| EPS (Diluted) | (9.35) | (6.01) | (4.61) | 0.19 | (34.67) |
| Weighted Avg Shares | 5.34M | 5.34M | 6.51M | 7.57M | 8.46M |
| Weighted Avg Shares (Diluted) | 5.34M | 5.34M | 6.51M | 7.57M | 8.46M |
Minerva Neurosciences, Inc.
NASDAQ:NERV
Intrinsic Alpha fair value
Locked
Current Price
$2.18
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.